van de Velde CJ - Search Results

1

A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.

Hoogstins CE, Tummers QR, Gaarenstroom KN, de Kroon CD, Trimbos JB, Bosse T, Smit VT, Vuyk J, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. Hoogstins CE, et al. Among authors: de kroon cd, van de velde cj. Clin Cancer Res. 2016 Jun 15;22(12):2929-38. doi: 10.1158/1078-0432.CCR-15-2640. Clin Cancer Res. 2016. PMID: 27306792 Clinical Trial.

2

Treatment of colorectal cancer metastases confined to the liver.

Vahrmeijer AL, van Dierendonck JH, van de Velde CJ. Vahrmeijer AL, et al. Among authors: van dierendonck jh, van de velde cj. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1238-42. doi: 10.1016/0959-8049(95)00214-4. Eur J Cancer. 1995. PMID: 7577030 Review.

3

Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries.

Bunt AM, Hermans J, Smit VT, van de Velde CJ, Fleuren GJ, Bruijn JA. Bunt AM, et al. Among authors: van de velde cj. J Clin Oncol. 1995 Jan;13(1):19-25. doi: 10.1200/JCO.1995.13.1.19. J Clin Oncol. 1995. PMID: 7799019 Clinical Trial.

4

Mechanical factors influencing the incidence of burst abdomen.

Niggebrugge AH, Hansen BE, Trimbos JB, van de Velde CJ, Zwaveling A. Niggebrugge AH, et al. Among authors: van de velde cj. Eur J Surg. 1995 Sep;161(9):655-61. Eur J Surg. 1995. PMID: 8541424

5

Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humans.

Vahrmeijer AL, Snel CA, Steenvoorden DP, Beijnen JH, Pang KS, Schutrups J, Tirona R, Keizer HJ, van Dierendonck JH, van de Velde CJ, Mulder GJ. Vahrmeijer AL, et al. Among authors: van dierendonck jh, van de velde cj. Cancer Res. 1996 Oct 15;56(20):4709-14. Cancer Res. 1996. PMID: 8840988 Clinical Trial.

6

Continuous double loop closure: a new technique for repair of laparotomy wounds.

Niggebrugge AH, Trimbos JB, Hermans J, Knippenberg B, van de Velde CJ. Niggebrugge AH, et al. Among authors: van de velde cj. Br J Surg. 1997 Feb;84(2):258-61. Br J Surg. 1997. PMID: 9052450

7

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.

Kuppen PJ, Jonges LE, van de Velde CJ, Vahrmeijer AL, Tollenaar RA, Borel Rinkes IH, Eggermont AM. Kuppen PJ, et al. Among authors: van de velde cj. Br J Cancer. 1997;75(10):1497-500. doi: 10.1038/bjc.1997.255. Br J Cancer. 1997. PMID: 9166943 Free PMC article.

8

Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases?

Vahrmeijer AL, Van Der Eb MM, Van Dierendonck JH, Kuppen PJ, Van De Velde CJ. Vahrmeijer AL, et al. Among authors: van der eb mm, van dierendonck jh, van de velde cj. Semin Surg Oncol. 1998 Apr-May;14(3):262-8. doi: 10.1002/(sici)1098-2388(199804/05)14:3<262::aid-ssu11>3.0.co;2-w. Semin Surg Oncol. 1998. PMID: 9548610 Review.

9

Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases.

Marinelli A, Vahrmeijer AL, van de Velde CJ. Marinelli A, et al. Among authors: van de velde cj. Recent Results Cancer Res. 1998;147:83-94. doi: 10.1007/978-3-642-80460-1_9. Recent Results Cancer Res. 1998. PMID: 9670271 Review.

10

Influence of abdominal-wound closure technique on complications after surgery: a randomised study.

Niggebrugge AH, Trimbos JB, Hermans J, Steup WH, Van De Velde CJ. Niggebrugge AH, et al. Among authors: van de velde cj. Lancet. 1999 May 8;353(9164):1563-7. doi: 10.1016/S0140-6736(98)10181-2. Lancet. 1999. PMID: 10334254 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

989 results

Search Page